These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning. Kunnen B, Dietze MMA, Braat AJAT, Lam MGEH, Viergever MA, de Jong HWAM. Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282 [Abstract] [Full Text] [Related]
7. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization. Martí-Climent JM, Prieto E, Elosúa C, Rodríguez-Fraile M, Domínguez-Prado I, Vigil C, García-Velloso MJ, Arbizu J, Peñuelas I, Richter JA. Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412 [Abstract] [Full Text] [Related]
11. Monte Carlo simulation of PET and SPECT imaging of 90Y. Takahashi A, Himuro K, Yamashita Y, Komiya I, Baba S, Sasaki M. Med Phys; 2015 Apr; 42(4):1926-35. PubMed ID: 25832083 [Abstract] [Full Text] [Related]
12. Radioembolization lung shunt estimation based on a 90 Y pretreatment procedure: A phantom study. Kunnen B, van der Velden S, Bastiaannet R, Lam MGEH, Viergever MA, de Jong HWAM. Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259 [Abstract] [Full Text] [Related]
13. Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose. Khazaee M, Kamali-Asl A, Geramifar P, Rahmim A. Nucl Med Commun; 2017 Nov; 38(11):985-997. PubMed ID: 28902765 [Abstract] [Full Text] [Related]
14. Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for 90 Y imaging and dosimetry optimization: A quantitative study. Trotta N, Collette B, Mathey C, Vierasu I, Bucalau AM, Verset G, Moreno-Reyes R, Goldman S. Med Phys; 2022 Dec; 49(12):7567-7582. PubMed ID: 35894818 [Abstract] [Full Text] [Related]
15. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. Lea WB, Tapp KN, Tann M, Hutchins GD, Fletcher JW, Johnson MS. J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647 [Abstract] [Full Text] [Related]
16. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma. Eaton BR, Kim HS, Schreibmann E, Schuster DM, Galt JR, Barron B, Kim S, Liu Y, Landry J, Fox T. J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792 [Abstract] [Full Text] [Related]